• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康衰老时大脑萎缩与 CSF 中 Aβ1-42 水平有关。

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

机构信息

Center for the Study of Human Cognition, Department of Psychology, University of Oslo, Oslo, Norway.

出版信息

Cereb Cortex. 2010 Sep;20(9):2069-79. doi: 10.1093/cercor/bhp279. Epub 2010 Jan 4.

DOI:10.1093/cercor/bhp279
PMID:20051356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3025722/
Abstract

Reduced levels of beta-amyloid(1-42) (Abeta1-42) and increased levels of tau proteins in the cerebrospinal fluid (CSF) are found in Alzheimer's disease (AD), likely reflecting Abeta deposition in plaques and neuronal and axonal damage. It is not known whether these biomarkers are associated with brain atrophy also in healthy aging. We tested the relationship between CSF levels of Abeta1-42 and tau (total tau and tau phosphorylated at threonine 181) proteins and 1-year brain atrophy in 71 cognitively normal elderly individuals. Results showed that under a certain threshold value, levels of Abeta1-42 correlated highly with 1-year change in a wide range of brain areas. The strongest relationships were not found in the regions most vulnerable early in AD. Above the threshold level, Abeta1-42 was not related to brain changes, but significant volume reductions as well as ventricular expansion were still seen. It is concluded that Abeta1-42 correlates with brain atrophy and ventricular expansion in a subgroup of cognitively normal elderly individuals but that reductions independent of CSF levels of Abeta1-42 is common. Further research and follow-up examinations over several years are needed to test whether degenerative pathology will eventually develop in the group of cognitively normal elderly individuals with low levels of Abeta1-42.

摘要

脑脊液(CSF)中β-淀粉样蛋白(1-42)(Abeta1-42)水平降低和tau 蛋白水平升高与阿尔茨海默病(AD)有关,可能反映了斑块中的 Abeta 沉积以及神经元和轴突损伤。目前尚不清楚这些生物标志物是否与健康衰老时的脑萎缩有关。我们在 71 名认知正常的老年人中测试了 CSF 中 Abeta1-42 和 tau(总 tau 和在苏氨酸 181 处磷酸化的 tau)蛋白水平与 1 年脑萎缩之间的关系。结果表明,在一定的阈值下,Abeta1-42 水平与广泛脑区的 1 年变化高度相关。最强的相关性并非出现在 AD 早期最易受损的区域。在阈值以上,Abeta1-42 与脑变化无关,但仍可见明显的体积减少和脑室扩张。结论是,Abeta1-42 与认知正常老年人亚组的脑萎缩和脑室扩张相关,但独立于 CSF Abeta1-42 水平的减少很常见。需要进一步的研究和多年的随访检查,以测试 Abeta1-42 水平较低的认知正常老年人组是否最终会出现退行性病理。

相似文献

1
Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.健康衰老时大脑萎缩与 CSF 中 Aβ1-42 水平有关。
Cereb Cortex. 2010 Sep;20(9):2069-79. doi: 10.1093/cercor/bhp279. Epub 2010 Jan 4.
2
Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.认知正常的老年人群中,脑脊液 Aβ1-42 水平较低者脑萎缩速度加快。
Ann Neurol. 2010 Dec;68(6):825-34. doi: 10.1002/ana.22315.
3
The role of clusterin in amyloid-β-associated neurodegeneration.簇集蛋白在淀粉样β相关神经退行性变中的作用。
JAMA Neurol. 2014 Feb;71(2):180-7. doi: 10.1001/jamaneurol.2013.4560.
4
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.脑脊液β淀粉样蛋白42(Abeta[42])水平降低与认知正常老年人的脑萎缩相关。
Ann Neurol. 2009 Feb;65(2):176-83. doi: 10.1002/ana.21559.
5
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
6
Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.疑似正常压力脑积水患者脑间质液中β淀粉样蛋白和 Tau 蛋白的动态变化
J Alzheimers Dis. 2015;46(1):261-9. doi: 10.3233/JAD-142862.
7
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.从阿尔茨海默病临床前期到痴呆阶段的认知、脑萎缩和脑脊液生物标志物变化以及载脂蛋白E的影响
J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451.
8
Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting.在临床环境中比较脑脊液生物标志物和淀粉样 PET 的诊断性能。
J Alzheimers Dis. 2020;74(2):473-490. doi: 10.3233/JAD-191109.
9
Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.社交网络与认知正常老年人阿尔茨海默病病理的脑脊液生物标志物:CABLE 研究。
J Alzheimers Dis. 2021;81(1):263-272. doi: 10.3233/JAD-201426.
10
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.脑脊液Aβ1-42/Aβ1-40比值可提高在临床环境中与淀粉样蛋白PET诊断阿尔茨海默病的一致性。
J Alzheimers Dis. 2017;60(2):561-576. doi: 10.3233/JAD-170327.

引用本文的文献

1
Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly.基线时海马体体积较小与健康老年人更大的体积损失相关。
Front Aging Neurosci. 2025 Jul 16;17:1542857. doi: 10.3389/fnagi.2025.1542857. eCollection 2025.
2
Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts.在最早的阿尔茨海默病连续体中,可溶性淀粉样β蛋白病理独立于磷酸化tau蛋白预测神经退行性变和认知衰退:来自两个独立队列的证据。
Alzheimers Dement. 2025 Feb;21(2):e14415. doi: 10.1002/alz.14415. Epub 2025 Feb 3.
3
The Aging Patterns of Brain Structure, Function, and Energy Metabolism.大脑结构、功能和能量代谢的衰老模式。
Adv Exp Med Biol. 2023;1419:85-97. doi: 10.1007/978-981-99-1627-6_7.
4
Neuroimaging Studies of the Neural Correlates of Heart Rate Variability: A Systematic Review.心率变异性神经关联的神经影像学研究:一项系统综述。
J Clin Med. 2023 Jan 28;12(3):1016. doi: 10.3390/jcm12031016.
5
Promoting successful participation of people living with Alzheimer's disease and related dementias in pain-related neuroimaging research studies.促进阿尔茨海默病及相关痴呆症患者成功参与疼痛相关的神经影像学研究。
Front Pain Res (Lausanne). 2022 Aug 19;3:926459. doi: 10.3389/fpain.2022.926459. eCollection 2022.
6
Cerebrospinal fluid biomarkers in Parkinson's disease with freezing of gait: an exploratory analysis.帕金森病冻结步态患者的脑脊液生物标志物:一项探索性分析。
NPJ Parkinsons Dis. 2021 Nov 29;7(1):105. doi: 10.1038/s41531-021-00247-x.
7
Regional age-related atrophy after screening for preclinical alzheimer disease.区域性与年龄相关的萎缩在临床前期阿尔茨海默病的筛查后。
Neurobiol Aging. 2022 Jan;109:43-51. doi: 10.1016/j.neurobiolaging.2021.09.010. Epub 2021 Sep 15.
8
Graph Models of Pathology Spread in Alzheimer's Disease: An Alternative to Conventional Graph Theoretic Analysis.阿尔茨海默病中病理学传播的图模型:对传统图论分析的一种替代方法。
Brain Connect. 2021 Dec;11(10):799-814. doi: 10.1089/brain.2020.0905. Epub 2021 May 25.
9
Within-session verbal learning slope is predictive of lifespan delayed recall, hippocampal volume, and memory training benefit, and is heritable.会话内言语学习斜率可预测寿命延迟回忆、海马体体积和记忆训练获益,且具有遗传性。
Sci Rep. 2020 Dec 3;10(1):21158. doi: 10.1038/s41598-020-78225-1.
10
A multipredictor model to predict the conversion of mild cognitive impairment to Alzheimer's disease by using a predictive nomogram.使用预测列线图预测轻度认知障碍向阿尔茨海默病转化的多预测因子模型。
Neuropsychopharmacology. 2020 Jan;45(2):358-366. doi: 10.1038/s41386-019-0551-0. Epub 2019 Oct 21.

本文引用的文献

1
Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach.通过将 EEG 和 MEG 与 MRI 皮质表面重建相结合来提高皮质活动的本地化:一种线性方法。
J Cogn Neurosci. 1993 Spring;5(2):162-76. doi: 10.1162/jocn.1993.5.2.162.
2
Subregional neuroanatomical change as a biomarker for Alzheimer's disease.亚区域神经解剖学变化作为阿尔茨海默病的生物标志物。
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20954-9. doi: 10.1073/pnas.0906053106.
3
Amyloid beta and APP as biomarkers for Alzheimer's disease.淀粉样β蛋白和 APP 作为阿尔茨海默病的生物标志物。
Exp Gerontol. 2010 Jan;45(1):23-9. doi: 10.1016/j.exger.2009.08.002. Epub 2009 Aug 19.
4
Consistent neuroanatomical age-related volume differences across multiple samples.跨多个样本的一致的神经解剖学与年龄相关的体积差异。
Neurobiol Aging. 2011 May;32(5):916-32. doi: 10.1016/j.neurobiolaging.2009.05.013. Epub 2009 Jun 30.
5
Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.处于阿尔茨海默病三种遗传风险水平的认知正常人群中的纤维状β淀粉样蛋白负荷
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6820-5. doi: 10.1073/pnas.0900345106. Epub 2009 Apr 3.
6
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.阿尔茨海默病神经影像学计划受试者的脑脊液生物标志物特征
Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610.
7
Structural MRI biomarkers for preclinical and mild Alzheimer's disease.用于临床前和轻度阿尔茨海默病的结构磁共振成像生物标志物
Hum Brain Mapp. 2009 Oct;30(10):3238-53. doi: 10.1002/hbm.20744.
8
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.脑脊液β淀粉样蛋白42(Abeta[42])水平降低与认知正常老年人的脑萎缩相关。
Ann Neurol. 2009 Feb;65(2):176-83. doi: 10.1002/ana.21559.
9
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.早期阿尔茨海默病中海马体积丢失与载脂蛋白E基因型及生物标志物关系的磁共振成像研究
Brain. 2009 Apr;132(Pt 4):1067-77. doi: 10.1093/brain/awp007. Epub 2009 Feb 27.
10
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.在240名患有阿尔茨海默病、轻度认知障碍的受试者以及老年对照组中,绘制心室扩张与脑脊液淀粉样蛋白和tau生物标志物之间的相关性。
Neuroimage. 2009 Jun;46(2):394-410. doi: 10.1016/j.neuroimage.2009.02.015. Epub 2009 Feb 21.